Comparison between Rolex Rings IPO and Windlas Biotech IPO.
Rolex Rings IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Rolex Rings IPO is up to ₹731.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Rolex Rings IPO is ₹900.00 per share and of Windlas Biotech IPO is ₹460.00 per share.
| Rolex Rings IPO | Windlas Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹5 per share |
| Issue Price (Lower) | ₹880.00 per share | ₹448.00 per share |
| Issue Price (Upper) | ₹900.00 per share | ₹460.00 per share |
| Issue Price (Final) | ₹900.00 per share | ₹460.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 16 shares | 30 shares |
| Fresh Issue Size | 6,22,222 shares | 35,86,956 shares |
| Fresh Issue Size (Amount) | up to ₹56.00 Cr | up to ₹165.00 Cr |
| OFS Issue Size | 75,00,000 shares | 51,42,067 shares |
| OFS Issue Size (Amount) | up to ₹675.00 Cr | up to ₹236.54 Cr |
| Issue Size Total | 81,22,222 shares | 87,29,023 shares |
| Issue Size Total (Amount) | up to ₹731.00 Cr | up to ₹401.54 Cr |
Rolex Rings IPO opens on Jul 28, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Rolex Rings IPO and Windlas Biotech IPO is Jul 30, 2021, and Aug 06, 2021, respectively.
| Rolex Rings IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Jul 27, 2021 | Aug 03, 2021 |
| Issue Open | Jul 28, 2021 | Aug 04, 2021 |
| Issue Close | Jul 30, 2021 | Aug 06, 2021 |
| Basis Of Allotment (Tentative) | Aug 04, 2021 | Aug 11, 2021 |
| Initiation of Refunds (Tentative) | Aug 05, 2021 | Aug 12, 2021 |
| Credit of Share (Tentative) | Aug 06, 2021 | Aug 13, 2021 |
| Listing date (Tentative) | Aug 09, 2021 | Aug 16, 2021 |
| Anchor Lockin End date 1 | Sep 03, 2021 | Sep 10, 2021 |
| Anchor Lockin End date 2 | Nov 02, 2021 | Nov 09, 2021 |
Rolex Rings IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .
| Rolex Rings IPO | Windlas Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 58.99 | 78 | ||||
| Promoter Shareholding (Post-Issue) | 57.64 | 65.16 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹2451.00 Cr. | ₹1002.54 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Rolex Rings IPO Retail Individual Investors (RII) are offered 28,42,778 shares while in Windlas Biotech IPO retail investors are offered 28,42,778 shares. Qualified Institutional Buyers (QIB) are offered 16,24,444 shares in Rolex Rings IPO and 17,45,804 shares in Windlas Biotech IPO.
| Rolex Rings IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 24,36,666 shares | 26,18,706 shares |
| Market Maker Reservation | ||
| QIB | 16,24,444 shares | 17,45,804 shares |
| NII | 12,18,334 shares | 13,09,354 shares |
| RII | 28,42,778 shares | 30,55,159 shares |
| Employee | ||
| Others | ||
| Total | 81,22,222 shares | 87,29,023 shares |
Rolex Rings IPO subscribed 130.44x in total, whereas Windlas Biotech IPO subscribed 22.44x.
| Rolex Rings IPO | Windlas Biotech IPO | |
|---|---|---|
| QIB (times) | 143.58x | 24.40x |
| NII (times) | 360.11x | 15.73x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 24.49x | 24.22x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 130.44x | 22.44x |
